Chronic Myeloproliferative Diseases on a Pathologist's Desk - A Dilemma of Distinct Entities versus a Clinico-Pathologic Continuum. A Descriptive Study Based on a Material from the Polish Population

Polish Journal of Pathology

Volumn 55, Issue 1, 2004, Pages 13-23

  Rudzki, Zbigniew ^a,b   Papla, Bolesław ^a   Stachura, Jerzy ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Dept of Clin/Exp Pathomorphology ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLAND; POLYCYTHEMIA VERA; THROMBOCYTHEMIA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; POLAND;

EID: 2342641959     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Anderson JE, Tefferi A, Craig F, Holmberg L, Chauncey T, Appelbaum FR, Guardiola P, Callander N, Freytes C, Gazitt Y, Razvillas B, Deeg HJ: Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis. Blood 2001, 98, 586-593.
2. Annaloro C, Lambertenghi Deliliers G, Oriani A, Pozzoli E, Lambertenghi Deliliers D, Radaelli F, Faccini P: Prognostic significance of bone marrow biopsy in essential thrombocythemia. Haematologica 1999, 84, 17-21.
3. Bauermeister DE: Quantitation of bone marrow reticulin - a normal range. Am J Clin Pathol 1971, 56, 24-31.
4. Berlin NI: Diagnosis and classification of the polycythemias. Semin Hematol 1975, 12, 339-351.
5. Cenantes F, Alvarez-Larran A, Talarn C, Gomez M, Montserrat E: Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. Br J Haematol 2002, 118, 786-790.
6. Cervantes F, Pereira A, Esteve J, Cobo F, Rozman C, Montserrat E: The changing profile of idiopathic myelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades. Eur J Haematol 1998, 60, 101-105.
7. Cervantes F, Pereira A, Esteve J, Rafael M, Cobo F, Rozman C, Montserrat E: Identification of "short-lived" and "long-lived" patients at presentation of idiopathic myelofibrosis. Br J Haematol 1997, 97, 635-640.
8. Dupriez B, Morel P, Demory JL, Lai JL, Simon M, Plantier I, Bauters F: Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996, 88, 1013-1018.
9. Georgii A, Buhr T, Buesche G, Kreft A, Choritz H: Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leukemia Lymphoma 1996, 22(supp 1), 15-29.
10. Georgii A, Vykoupil KF, Buhr T, Choritz H, Dohler U, Kaloutsi V, Werner M: Chronic myeloproliferative disorders in bone marrow biopsies. Pathol Res Pract 1990, 186, 3-27.
11. Guardiola P, Anderson JE, Bandini G, Cervantes F, Runde V, Arcese W, Bacigalupo A, Przepiorka D, O'Donnell MR, Polchi P, Buzyn A, Sutton L, Cazals-Hatem D, Sale G, de Witte T, Deeg HJ, Gluckman E: Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood 1999, 93, 2831-2838.
12. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001.
13. Jantunen R, Juvonen E, Ikkala E, Oksanen K, Anttila P, Ruutu T: Development of erythrocytosis in the course of essential thrombocythemia. Ann Hematol 1999, 78, 219-222.
14. Jensen MK, de Nully Brown P, Nielsen OJ, Hasselbalch HC: Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area. Eur J Haematol 2000, 65, 132-139.
15. Lamy T, Devillers A, Bernard M, Moisan A, Grulois I, Drenou B, Amiot L, Fauchet R, Le Prise PY: Inapparent polycythemia vera: an unrecognized diagnosis. Am J Med 1997, 102, 14-20.
16. Laszlo J. Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 1975, 12, 409-432.
17. Lengfelder E, Hochhaus A, Kronawitter U, Hoche D, Queisser W, Jahn-Eder M, Burkhardt R, Reiter A, Ansari H, Hehlmann R: Should a platelet limit of 600×10(9)/1 be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br J Haematol 1998, 100, 15-23.
18. Murphy S, Peterson P, Hand H, Laszlo J: Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997, 34, 29-39.
19. Pearson TC, Messinezy M: The diagnostic criteria of polycythaemia rubra vera. Leukemia Lymphoma 1996, 22(suppl 1), 87-93.
20. Rozman C, Giralt M, Feliu E, Rubio D, Cortes MT: Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991, 67, 2658-2663.
21. Ruggeri M, Finazzi G, Tosetto A, Riva S, Rodeghiero F, Barbui T: No treatment for low-risk thrombocythaemia: results from a prospective study. Br J Haematol 1998, 103, 772-777.
22. Sacchi S, Vinci G, Gugliotta L, Rupoli S, Gargantini L, Martinelli V, Baravelli S, Lazzarino M, Finazzi G: Diagnosis of essential thrombocythemia at platelet counts between 400 and 600×10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche (GIMMC). Haematologica 2000, 85, 492-425.
23. Shih LY, Lee CT: Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood 1994, 83, 744-748.
24. Thiele J, Kvasnicka HM, Fischer R: Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification. Ann Hematol 1999, 78, 495-506.
25. Thiele J, Kvasnicka HM, Schmitt-Graeff A, Zankovich R, Diehl V: Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients. Am J Hematol 2002, 70, 283-291.
26. Thiele J, Kvasnicka HM, Zankovich R, Diehl V: Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Ann Hematol 2001, 80, 160-165.
27. Thiele J, Kvasnicka HM, Zankovich R, Diehl V: Early-stage idiopathic (primary) myelofibrosis - current issues of diagnostic features. Leukemia Lymphoma 2002, 43, 1035-1041.